Science

Cancer survivors infected with COVID-19 in the early months of the pandemic had a higher risk of dying from dormant cells reawakening, Colorado researchers found, though they don’t know whether people who get the virus now face the same risk. Experiments in mice found that genetically modified animals were more likely to have signs of metastatic cancer in their lungs if infected with flu or COVID-19 than engineered mice that researchers didn’t give a virus, said James DeGregori, deputy director of the University of Colorado Cancer Center in Aurora. That finding launched an international partnership to determine whether the same thing happened in people, he said. DeGregori was one of the lead investigators, alongside scientists from Utrecht University in the Netherlands, Imperial College London, University College London, University of Connecticut, Albert Einstein College of Medicine in New York City, Children’s Hospital of Philadelphia, and the COVID-19 International Research Tea...

By Asuka Koda, CNN Dr. Anna Wolfson says she sees dangerous misuse of the allergy medication diphenhydramine in her clinic every day. “If someone has an allergic reaction to a food, people will say, ‘Don’t worry, I have diphenhydramine in my purse,’ and I would say, ‘Really, epinephrine is the first-line treatment for food allergies,’” said Wolfson, an allergist at Massachusetts General Hospital. Related Articles Caregiver OneCall offers a lifeline to burned-out family caregivers Are tattooed beachgoers at risk for skin cancer? Bay Area Kaiser hospital earns national ranking for rehab care Hospital lawsuit accuses Santa Clara County of refusing full reimbursement for more than 5,000 patients Researchers across country warn of uptick in deadly flu complication affecting young children Diphenhydramine can be harmful if people take it after having an allergic reaction to food, she said, because the drug – best known by the brand name Benadryl – makes them drowsy and can cause...